Caribou Biosciences, Inc.

NASDAQ:CRBU

1.25 (USD) • At close July 1, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Omzet 2.3532.0772.0243.4642.4293.55823.6623.7553.5023.6923.3034.1922.6642.5593.9771.4761.5860.9841.1988.4781.701
Kosten van de omzet 0000.8560.711.9742.1061.1261.1040.9031.0720.8580.8080.27315.83312.32710.16512.0246.187.588.641
Brutowinst 2.3530.8932.0242.6081.7191.58421.5562.6292.3982.7892.2313.3341.8562.286-11.856-10.851-8.579-11.04-4.9820.898-6.94
Brutowinstmarge 10.4310.7530.7080.4450.9110.70.6850.7550.6750.7950.6970.893-2.981-7.352-5.409-11.22-4.1590.106-4.08
Onderzoek- en ontwikkelingskosten 35.53130.46430.42135.4833.78831.27928.58426.50325.70925.73619.99122.57913.92415.11115.83312.32710.16512.0246.187.588.641
Algemene en administratieve kosten 9.73510.4889.84111.48514.6439.7219.71110.128.9098.5349.84910.0449.5937.8536.765.1134.5964.1733.2473.1533.489
Verkoop- en marketingkosten 000-0.8560-1.974000000000000000
Verkoop-, algemene en administratieve kosten 9.73510.4889.84110.62914.6437.7479.71110.128.9098.5349.84910.0449.5937.8536.765.1134.5964.1733.2473.1533.489
Overige kosten 0005.9064.7683.1394.6353.3273.0873.719-0.1411.751.8532.171-2.380.0250.0170.0830.0850.3270.021
Bedrijfskosten 45.26640.95240.26246.10948.43139.02638.29536.62334.61834.2729.8432.62323.51722.96422.59317.4414.76116.1979.42710.73312.13
Bedrijfsresultaat -42.913-38.875-38.238-43.501-46.002-37.442-14.633-32.868-31.116-30.578-26.537-28.431-20.853-20.405-18.616-15.964-13.175-15.213-8.229-2.255-10.429
Bedrijfsresultaat ratio -18.238-18.717-18.892-12.558-18.939-10.523-0.618-8.753-8.885-8.282-8.034-6.782-7.828-7.974-4.681-10.816-8.307-15.46-6.869-0.266-6.131
Totaal overige inkomsten en kosten netto 2.9223.3763.5545.8044.7683.134.6313.3493.0723.659-0.111.7341.7652.247-2.3581.6530.0160.1560.0830.333-0.573
Inkomen voor belasting -39.991-35.499-34.684-37.697-41.234-34.312-10.002-29.519-28.044-26.919-26.647-26.697-19.088-18.158-20.974-14.311-13.159-15.057-8.146-1.922-11.002
Inkomen voor belasting ratio -16.996-17.091-17.136-10.883-16.976-9.644-0.423-7.861-8.008-7.291-8.068-6.369-7.165-7.096-5.274-9.696-8.297-15.302-6.8-0.227-6.468
Belastingkosten 0-0.00900-0.710.193-1.579-0.639-3.0570.070.11-1.734-1.7650.321-2.380.0270.022-0.354-0.213-0.05-1.202
Nettowinst -39.991-35.49-34.684-37.697-41.234-34.505-10.002-29.519-24.987-26.989-26.757-24.963-17.323-18.479-20.974-14.311-13.159-14.703-7.933-1.872-9.8
Nettowinstmarge -16.996-17.087-17.136-10.883-16.976-9.698-0.423-7.861-7.135-7.31-8.101-5.955-6.503-7.221-5.274-9.696-8.297-14.942-6.622-0.221-5.761
WPA (Winst Per Aandeel) -0.43-0.39-0.38-0.42-0.46-0.39-0.12-0.48-0.41-0.44-0.44-0.41-0.29-0.31-0.46-0.26-0.48-0.53-0.29-0.068-0.35
Verwaterde WPA -0.43-0.39-0.38-0.42-0.46-0.39-0.12-0.48-0.41-0.44-0.44-0.41-0.29-0.31-0.46-0.26-0.48-0.53-0.29-0.068-0.35
EBITDA -41.748-37.691-38.238-42.645-45.292-36.702-13.054-32.251-30.527-32.645-26.087-28.073-20.545-17.885-18.356-15.734-12.954-14.831-7.914-1.689-10.773
EBITDA ratio -17.742-18.147-18.892-12.311-18.646-10.315-0.552-8.589-8.717-8.842-7.898-6.697-7.712-6.989-4.616-10.66-8.168-15.072-6.606-0.199-6.333